Growing investments in research & development to develop effective remedies and increased involvement of many public and private firms in developing effective treatments for sarcopenia are expected to propel the growth of market in near future
PUNE, India, Nov. 27, 2019 /PRNewswire/ -- Research Dive published a report, titled, "Sarcopenia Treatment Market: Global Opportunity Analysis and Industry Forecast, 2019-2026". According to the report, the global market size of sarcopenia treatment was valued at $2.74 billion in 2018 and is expected to reach $3.975 billion by 2026, and register a CAGR of 4.7% from 2018 to 2026.
Download Request Sample at https://www.researchdive.com/download-sample/24
Prime determinants of growth
Growing investments in research & development to develop effective therapies and increased involvement of many public and private firms in developing effective treatments for sarcopenia are factors expected to propel the growth of market in near future. However, lack of awareness in the geriatric population leads to poor diagnosis of this disease and hence, limits treatment adoption. Also, lack of effective therapies to treat the disorder is a major factor making an adverse impact on the market growth.
Protein supplement segment to continue its dominant position throughout the forecast period
By treatment type, the protein supplement segment contributed the highest market share in the global sarcopenia treatment market in 2018, holding nearly three-fifths of the total share, and is projected to continue its dominant position during the forecast period. Also, this segment is expected to grow at the highest CAGR of 5.1% from 2019 to 2026. The research also analyzes segments including Vitamin B 12 Supplement, Vitamin D and Calcium Supplement.
Retail Channels segment to maintain its highest share by 2026
Based on distribution channel, the retail channels segment held nearly half of the total market share of the global sarcopenia treatment market in 2018, and will uphold its highest share by 2026. Moreover, this segment is anticipated to grow at the highest CAGR of 5.3% from 2019 to 2026. The research also evaluates segments including Hospitals and Online Channels.
Get 10% Discount on Customization at https://www.researchdive.com/request-for-customization/24
North America to maintain its lead position during the forecast period
Based on region, North America accounted for the major market share, contributing for nearly two-fifths of the total share of the global sarcopenia treatment industry in 2018, and will sustain its lead position throughout the forecast period. On the other hand, Asia Pacific would grow at the highest CAGR of 5.0% from 2019 to 2026.
Leading industry players
- Five Prime Therapeutics, Inc
- GlaxoSmithKline plc
- Pfizer Inc.
- Sanofi S.A.
- Cadila Healthcare Ltd
- Novartis AG
- Bayer AG
- Nestlé S.A.
- Abbott Laboratories
- Radius Health Inc
- Eli Lilly and Company
- Others
Similar Reports:
- North America Orthopedic Implants Market
North American orthopedic implants market accounted for $23,461 million in 2018 is expected to reach $30,646 million by 2025, registering a CAGR of 3.9% from 2019 to 2025. - North America Patient Centric Healthcare App Market
The North America Patient Centric Healthcare App market was valued at $7,013 million in 2018, and is projected to reach $57,493 million by 2025, growing at a CAGR of 34.8% from 2019 to 2025.
About Us:
Research Dive is a market research firm based in Pune, India. Maintaining the integrity and authenticity of the services, the firm provides the services that are solely based on its exclusive data model, compelled by the 360-degree research methodology, which guarantees comprehensive and accurate analysis. With an unprecedented access to several paid data resources, team of expert researchers, and strict work ethic, the firm offers insights that are extremely precise and reliable. Scrutinizing relevant news releases, government publications, decades of trade data, and technical & white papers, Research dive deliver the required services to its clients well within the required timeframe. Its expertise is focused on examining niche markets, targeting its major driving factors, and spotting threatening hindrances. Complementarily, it also has a seamless collaboration with the major industry aficionado that further offers its research an edge.
Contact:
Mr. Abhishek Paliwal
Research Dive
30 Wall St. 8th Floor, New York
NY 10005 (P)
+ 91(788) 802-9103 (India)
+1(917) 444-1262 (US)
Toll Free: +1-888-961-4454
E-mail: support@researchdive.com
Website: https://www.researchdive.com
LinkedIn: https://www.linkedin.com/company/research-dive/
Twitter: https://twitter.com/ResearchDive
Facebook: https://www.facebook.com/Research-Dive-1385542314927521
Logo: https://mma.prnewswire.com/media/997523/Research_Dive_Logo.jpg
